Page 1 of Clinical Trials for Subfoveal Neovascular Age-Related Macular Degeneration, 32 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Study of Ranibizumab Administered Monthly or on an As-Needed Basis in Patients With Subfoveal Neovascular Age-Related Macular Degeneration (HARBOR)
Last Updated: March 28, 2012
Condition(s): Macular Degeneration
2
Completed
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration
Last Updated: September 1, 2009
Condition(s): Macular Degeneration
3
Completed
A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
Last Updated: September 1, 2009
Condition(s): Macular Degeneration
4
Active, not recruiting
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Last Updated: February 27, 2012
Condition(s): Age Related Macular Degeneration; Choroidal Neovascular Membrane; Subfoveal Neovascular Age-Related Macular Degeneration; Macular Degeneration; Wet Age-Related Macular Degeneration
5
Recruiting
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
Last Updated: January 12, 2007
Condition(s): Age-Related Macular Degeneration (AMD)
6
Terminated
A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
Last Updated: January 12, 2007
Condition(s): Macular Degeneration
7
Recruiting
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)
Last Updated: February 23, 2011
Condition(s): Age Related Macular Degeneration; Choroidal Neovascularization
8
Completed
A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
Last Updated: September 1, 2009
Condition(s): Macular Degeneration
9
Completed
Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)
Last Updated: November 17, 2009
Condition(s): Macular Degeneration
10
Completed
Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
Last Updated: March 31, 2011
Condition(s): Age Related Macular Degeneration
11
Active, not recruiting
A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
Last Updated: April 30, 2012
Condition(s): Age-Related Macular Degeneration
12
Completed
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
Last Updated: June 9, 2011
Condition(s): Macular Degeneration
13
Completed
A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
Last Updated: January 21, 2010
Condition(s): Age-Related Macular Degeneration
14
Completed
ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration
Last Updated: October 4, 2011
Condition(s): Age-Related Macular Degeneration
15
Completed
Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
Last Updated: June 8, 2011
Condition(s): Macular Degeneration
16
Completed
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
Last Updated: January 27, 2012
Condition(s): Macular Degeneration
17
Completed
Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD
Last Updated: October 29, 2009
Condition(s): Neovascular Age Related Macular Degeneration
18
Recruiting
Home Vision Monitoring in AREDS2 for Progression to Neovascular Age-Related Macular Degeneration
Last Updated: March 20, 2012
Condition(s): Age-Related Macular Degeneration
19
Completed
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
Last Updated: December 1, 2010
Condition(s): Age Related Macular Degeneration; Choroidal Neovascularization; Macular Edema
20
Completed
Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
Last Updated: March 15, 2010
Condition(s): Macular Degeneration

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Subfoveal+Neovascular+Age-Related+Macular+Degeneration

Page 1 of Clinical Trials for Subfoveal Neovascular Age-Related Macular Degeneration, 32 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About